Notice Type
Departmental
Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Mycophenolate mofetil 250 mg Capsule Syntex Puerto Rico Inc., Humacao, Puerto Rico and Roche Products Limited, Welwyn Garden City, Hertfordshire, United Kingdom CellCept Mycophenolate mofetil 500 mg Tablet Syntex Puerto Rico Inc., Humacao, Puerto Rico and Roche Products Limited, Welwyn Garden City, Hertfordshire, United Kingdom CellCept Terbinafine hydrochloride 10 mg/g Solution, topical Novartis Pharma AG., Basel, Switzerland Lamisil Terbinafine hydrochloride 10 mg/g Spray, topical Novartis Pharma AG., Basel, Switzerland Lamisil Pravastatin sodium 5 mg, 10 mg. 20 mg Tablets Bristol-Myers Squibb Pharmaceuticals Pty Limited, Noble Park, Victoria, Australia Lipostat Pravastatin sodium 10 mg, 20 mg, 40 mg Tablets (reduced mass formulation) Bristol-Myers Squibb Pharmaceuticals Pty Limited, Noble Park, Victoria, Australia Lipostat Ropivacaine hydrochloride monohydrate 2 mg/mL Infusion, solution Astra Pharmaceuticals Pty Limited, North Ryde, New South Wales, Australia and NPBI BV., Emmer-Compascuum, The Netherlands Naropin Varicella vaccine 2,000PFU in 0.5 mL Injection, solution SmithKline Beecham Biologicals Manufacturing, Rixensart, Belgium Varilrix Simvastatin 5 mg, 10 mg, 20 mg, 40 mg Tablets, film coated Merck Sharp & Dohme Limited, Cramlington, Northumberland, England; Merck Sharp & Dohme (Aust) Pty Limited, South Granville, New South Wales, Australia and Merck & Co Inc., West Point, Pennsylvania, United States of America Zocor Simvastatin 80 mg Tablet, film coated Merck Sharp & Dohme Limited, Cramlington, Northumberland, England Zocor Dated this 20th day of February 1999. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
Publication Date
25 Feb 1999

Notice Number

1999-go1479

Page Number

564